You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progression-free survival

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors, KRAS Mutation Trial in Worldwide (BI 1823911, BI 1701963, Midazolam)

Recruiting
  • Solid Tumors, KRAS Mutation
  • BI 1823911
  • +2 more
  • New York, New York
  • +8 more
Aug 10, 2022

Lung Tumors Trial (Envafolimab, Endostar)

Not yet recruiting
  • Lung Neoplasms
  • (no location specified)
Feb 8, 2022

Tumor Metastasis Trial in Groningen, Stockholm,, Bern (Microwave ablation, Resection)

Completed
  • Neoplasm Metastasis
  • Microwave ablation
  • Resection
  • Groningen, Netherlands
  • +2 more
Mar 30, 2022

Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic Trial in France (Imatinib maintenance)

Recruiting
  • Gastrointestinal Stromal Tumors
  • +4 more
  • Imatinib maintenance
  • Marseille, Bouches Du Rhône, France
  • +16 more
Jul 28, 2021

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Recruiting
  • Non-small Cell Lung Cancer
    • Harlow, Essex, United Kingdom
    • +17 more
    Feb 22, 2022

    NSCLC, Non-Small-Cell Lung Carcinoma, Circulating Tumor DNA Trial (biological, drug, other)

    Withdrawn
    • Non-Small Cell Lung Cancer
    • +2 more
    • Nivolumab
    • +8 more
    • (no location specified)
    Mar 9, 2022

    Recurrent or Metastatic Nasopharyngeal Carcinoma Trial in China (MRG003)

    Recruiting
    • Recurrent or Metastatic Nasopharyngeal Carcinoma
    • Chongqing, Chongqing, China
    • +14 more
    Nov 18, 2021

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +6 more
    • Tucson, Arizona
    • +23 more
    Dec 14, 2021

    Relapsed/Refractory Multiple Myeloma Trial in United States (UCARTCS1A)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • UCARTCS1A
    • San Francisco, California
    • +4 more
    Nov 11, 2021

    Prostate Carcinoma Trial in Shanghai (carbon-ion radiotherapy)

    Recruiting
    • Prostate Carcinoma
    • carbon-ion radiotherapy
    • Shanghai, Shanghai, China
      Shanghai Proton and Heavy Ion Center
    Nov 12, 2021

    Advanced Colorectal Cancer Trial in Nanjing (Bevacizumab?Oxaliplatin?Irinotecan?Capecitabine)

    Recruiting
    • Advanced Colorectal Cancer
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Institute & Hospital
    Aug 27, 2021

    Prostate Cancer Metastatic Trial in United States (FOR46)

    Active, not recruiting
    • Prostate Cancer Metastatic
    • Los Angeles, California
    • +4 more
    May 9, 2022

    Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Leipzig, Germany
      Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
    Apr 25, 2023

    Lymphoma, Non-Hodgkin Trial in Worldwide (Copanlisib (BAY80-6946), Placebo, Rituximab)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Copanlisib (BAY80-6946)
    • +7 more
    • Chandler, Arizona
    • +199 more
    Jan 31, 2023

    Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)

    Active, not recruiting
    • Breast Neoplasms
    • Nagoya, Aichi, Japan
    • +22 more
    Apr 4, 2022

    NSCLC Trial in France, Korea, Republic of, United States (REGN5093)

    Recruiting
    • NSCLC
    • Birmingham, Alabama
    • +29 more
    Sep 22, 2022

    Tumors, Breast Tumors Trial in Japan (talazoparib)

    Active, not recruiting
    Has Results
    • Neoplasms
    • Breast Neoplasms
    • Nagoya, Aichi, Japan
    • +7 more
    Dec 20, 2021

    Diarrhea, Treatment Side Effects Trial in Guangzhou (Bacillus Cereus tablets)

    Terminated
    • Diarrhea
    • Treatment Side Effects
    • Bacillus Cereus tablets
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 27, 2021

    Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

    Not yet recruiting
    • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    • (no location specified)
    Jul 11, 2022

    Real-life Current Standards of Care in Relapsed and/or

    Completed
    • Multiple Myeloma
    • No intervention
    • Tucson, Arizona
    • +85 more
    Dec 20, 2022

    Thyroid Cancer Trial in New Haven, Boston (Regorafenib)

    Recruiting
    • Thyroid Cancer
    • New Haven, Connecticut
    • +1 more
    Feb 18, 2022

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +19 more
    • Proton Beam Radiation Therapy
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 5, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, abiraterone acetate)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Beijing, China
    • +35 more
    Aug 9, 2022

    Lymphocytic Leukemia, Chronic Trial in Worldwide (Chlorambucil, Venetoclax, Obinutuzumab)

    Active, not recruiting
    Has Results
    • Lymphocytic Leukemia, Chronic
    • Duarte, California
    • +136 more
    Dec 22, 2022

    Prostate Neoplams, Magnetic Resonance Imaging, Laser Ablation Trial in Nijmegen (Focal laser ablation)

    Recruiting
    • Prostate Neoplams, Magnetic Resonance Imaging, Laser Ablation
    • Focal laser ablation
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    Oct 25, 2022